Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Yu Zhang, MD"'
Autor:
Moises Hernandez, MD, Cristian Puerta, MD, Nikita Thareja, BS, Yu Zhang, MD, PhD, Travis Pollema, DO, Patricia Thistlethwaite, MD, PhD
Publikováno v:
HeartRhythm Case Reports, Vol 9, Iss 8, Pp 520-523 (2023)
Externí odkaz:
https://doaj.org/article/bde4b0d706314da0afa708a2ab1e4b35
Efficacy and safety of omalizumab against chronic spontaneous urticaria: Real-world study from China
Autor:
Ao Wang, MD, Yuhui Yun, MM, Zhihua Wen, MM, Yingxia Gao, BS, Shuzhen Qi, MD, Yu Zhang, MD, Yunsheng Liang, MD, Xu Yao, MD
Publikováno v:
World Allergy Organization Journal, Vol 15, Iss 12, Pp 100719- (2022)
Background: Omalizumab is an effective treatment for chronic spontaneous urticaria (CSU) patients aged ≥12 years, but its efficacy in patients aged
Externí odkaz:
https://doaj.org/article/dac56918325c4f1fabb9b0da6dcf55e2
Publikováno v:
Medicine, Vol 101, Iss 15, p e29181 (2022)
Abstract. Rationale:. Tracheal bronchus is an aberrant bronchus that arises directly from the carina of the trachea. It was rare, with only 0.1% to 2% on the right and 0.3% to 1% on the left side of the lateral wall. Tracheal bronchus is usually asym
Externí odkaz:
https://doaj.org/article/b4abbf6bac0046f1a536df0631175607
Autor:
Xi-yue Zhang Bachelor of Medicine, Ming Luo MD, Shu Qin MD, Wen-guang Fu MD, Meng-yu Zhang MD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 23 (2024)
Detect the expression of Farnesoid X Receptor(FXR), Multiple Drug Resistance Associated Protein-1(MRP-1) and Solute Carrier Family 7, Member 5 (SLC7A5) in hepatocellular carcinoma(HCC) of rat model, so as to provide new therapeutic targets for gene t
Externí odkaz:
https://doaj.org/article/176a7b7e1dec46f99f0ec02398d0a3a4
Autor:
Binwei Lin MM, Jinjia Fan MM, Fang Liu MD, Yixue Wen MM, Jie Li MD, Feng Gao MD, Yu Zhang MD, Gang Feng MM, Xiaobo Du MD, Wenzhi Chen MD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 22 (2023)
Introduction: This study aimed to compare the efficacy and safety of docetaxel + trastuzumab + pertuzumab and docetaxel + carboplatin + trastuzumab + pertuzumab for treating HER2-positive breast cancer. Method: HER2-positive breast cancer from patien
Externí odkaz:
https://doaj.org/article/6155f9c6dea543498514a275594783c3
Publikováno v:
Technology in Cancer Research & Treatment, Vol 22 (2023)
Objectives The restoration of as much normal function as possible has become an important goal following the endoprosthetic reconstruction. The objective of this study was to assess the functional outcome after endoprosthetic reconstruction for tumor
Externí odkaz:
https://doaj.org/article/4f3b88161775470aab2938a6ff6022cf
Publikováno v:
Technology in Cancer Research & Treatment, Vol 21 (2022)
Background: Forkhead box F2, a member of the Forkhead box transcription factor superfamily, plays an important role in several types of cancer. However, the mechanisms of Forkhead box F2 in the progression of colorectal cancer remain unclear. PRUNE2
Externí odkaz:
https://doaj.org/article/fbc9c9cf7b2645dc80060138ff83db75
Publikováno v:
Technology in Cancer Research & Treatment, Vol 21 (2022)
Background: The study aims to detect the expression of Na + /taurocholate cotransporter polypeptide in hilar cholangiocarcinoma of rat model, to provide a new therapeutic target for gene therapy of hilar cholangiocarcinoma. Methods: 60 male Wistar ra
Externí odkaz:
https://doaj.org/article/62dcd194a16047e9aada3e8b259b3d05
Autor:
Kaijing Wang, PhD, Zhe Zhu, PhD, Wei Gao, PhD, Tao Du, PhD, Zhen-Yu Zhang, MD, Meng-Chen Liu, MS, Jie Liu, MS, Yuan-Yuan Zhang, MS, Bing Lu, PhD, Chuan-Gang Fu, PhD
Publikováno v:
Asian Journal of Surgery, Vol 44, Iss 1, Pp 164-168 (2021)
Background: A few factors influence the feasibility of transrectal natural orifice specimen extraction (NOSE) surgery for colorectal cancers. However, little is known about the underlying factors of NOSE surgery. Methods: Consecutive patients with re
Externí odkaz:
https://doaj.org/article/cbdda31d6ab64d98b2c9b936a51e7bc7
Autor:
Qi-Fang Huang, MD, PhD, Sander Trenson, MD, Zhen-Yu Zhang, MD, Jan Van Keer, MD, Lucas N.L. Van Aelst, MD, PhD, Wen-Yi Yang, MD, Esther Nkuipou-Kenfack, PhD, Lutgarde Thijs, MSc, Fang-Fei Wei, MD, Blerim Mujaj, MD, Agnieszka Ciarka, MD, PhD, Walter Droogné, MD, PhD, Johan Vanhaecke, MD, PhD, Stefan Janssens, MD, PhD, Johan Van Cleemput, MD, PhD, Harald Mischak, PhD, Jan A. Staessen, MD, PhD
Publikováno v:
Transplantation Direct, Vol 4, Iss 5, p e346 (2018)
Background. This proof-of-concept study investigated the feasibility of using biomarkers to monitor right heart pressures (RHP) in heart transplanted (HTx) patients. Methods. In 298 patients, we measured 7.6 years post-HTx mean pressures in the right
Externí odkaz:
https://doaj.org/article/a8005fe02fba4b0fafecd70b69993307